Impaired expression of Toll-like receptor 2 in nontuberculous mycobacterial lung disease

European Respiratory Journal

Volumn 30, Issue 4, 2007, Pages 736-742

  Ryu, Y J ^a,b   Kim, E J ^a   Lee, S H ^a   Kim, S Y ^a   Suh, G Y ^a   Chung, M P ^a   Kim, H ^a   Kwon, O J ^a   Koh, W J ^a  

^a Sungkyunkwan University School of Medicine   (South Korea)

^b Ewha Womans University   (South Korea)

Author keywords

Atypical mycobacteria; Disease susceptibility; Lung diseases; Toll like receptor 2

Indexed keywords

INTERLEUKIN 12; LIPOTEICHOIC ACID; MESSENGER RNA; PROTEIN P40; TOLL LIKE RECEPTOR 2; TUMOR NECROSIS FACTOR ALPHA; CYTOKINE; INTERLEUKIN 12P40; LIPOPOLYSACCHARIDE; TEICHOIC ACID;

ADULT; ARTICLE; BLOOD; CELL; CELL RESPONSE; CELL STIMULATION; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOKINE RELEASE; DOWN REGULATION; FEMALE; GENE EXPRESSION; HOST SUSCEPTIBILITY; HUMAN; LUNG DISEASE; MALE; MONOCYTE; MYCOBACTERIUM AVIUM; NONTUBERCULOUS MYCOBACTERIAL LUNG DISEASE; PRIORITY JOURNAL; PROTEIN SECRETION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; BIOSYNTHESIS; GENE EXPRESSION REGULATION; GENETIC PREDISPOSITION; METABOLISM; MICROBIOLOGY; MIDDLE AGED; MYCOBACTERIOSIS; TIME;

CYTOKINES; FEMALE; GENE EXPRESSION REGULATION; GENETIC PREDISPOSITION TO DISEASE; HUMANS; INTERLEUKIN-12 SUBUNIT P40; LIPOPOLYSACCHARIDES; LUNG DISEASES; MALE; MIDDLE AGED; MONOCYTES; MYCOBACTERIUM AVIUM; MYCOBACTERIUM INFECTIONS; RNA, MESSENGER; TEICHOIC ACIDS; TIME FACTORS; TOLL-LIKE RECEPTOR 2; TUMOR NECROSIS FACTOR-ALPHA;

EID: 38449087398     PISSN: 09031936     EISSN: None     Source Type: Journal    
DOI: 10.1183/09031936.00039507     Document Type: Article

References (30)

1. Wallace RJ Jr, Cook JL, Glassroth J, Griffith DE, Olivier KN, Gordin F. American Thoracic Society statement: diagnosis and treatment of disease caused by nontuberculous mycobacteria. Am J Respir Crit Care Med 1997; 156: S1-S25.
2. Griffith DE, Aksamit T, Brown-Elliott BA, et al. An official ATS/IDSA statement: diagnosis, treatment, and prevention of nontuberculous mycobacterial diseases. Am J Respir Crit Care Med 2007; 175: 367-416.
3. Dailloux M, Abalain ML, Laurain C, et al. Respiratory infections associated with nontuberculous mycobacteria in non-HIV patients. Eur Respir J 2006; 28: 1211-1215.
4. Koh WJ, Kwon OJ, Lee KS. Diagnosis and treatment of nontuberculous mycobacterial pulmonary diseases: a Korean perspective. J Korean Med Sci 2005; 20: 913-925.
5. Guide SV, Holland SM. Host susceptibility factors in mycobacterial infection. Genetics and body morphotype. Infect Dis Clin North Am 2002; 16: 163-186.
6. Hwang JH, Koh WJ, Kim EJ, et al. Partial interferon-γ receptor deficiency and non-tuberculous mycobacterial lung disease. Tuberculosis (Edinb) 2006; 86: 382-385.
7. Koh WJ, Kwon OJ, Kim EJ, Lee KS, Ki CS, Kim JW. NRAMP1 gene polymorphism and susceptibility to nontuberculous mycobacterial lung diseases. Chest 2005; 128: 94-101.
8. Quesniaux V, Fremond C, Jacobs M, et al. Toll-like receptor pathways in the immune responses to mycobacteria. Microbes Infect 2004; 6: 946-959.
9. Ryffel B, Fremond C, Jacobs M, et al. Innate immunity to mycobacterial infection in mice: critical role for Toll-like receptors. Tuberculosis (Edinb) 2005; 85: 395-405.
10. Heldwein KA, Fenton MJ. The role of Toll-like receptors in immunity against mycobacterial infection. Microbes Infect 2002; 4: 937-944.
11. Akira S, Takeda K. Toll-like receptor signalling. Nat Rev Immunol 2004; 4: 499-511.
12. Wang T, Lafuse WP, Zwilling BS. Regulation of Toll-like receptor 2 expression by macrophages following Mycobacterium avium infection. J Immunol 2000; 165: 6308-6313.
13. Alvarez GR, Zwilling BS, Lafuse WP. Mycobacterium avium inhibition of IFN-γ signaling in mouse macrophages: Toll-like receptor 2 stimulation increases expression of dominant-negative STAT1β by mRNA stabilization. J Immunol 2003; 171: 6766-6773.
14. Gomes MS, Flórido M, Cordeiro JV, et al. Limited role of the Toll-like receptor-2 in resistance to Mycobacterium avium. Immunology 2004; 111: 179-185.
15. Feng CG, Scanga CA, Collazo-Custodio CM, et al. Mice lacking myeloid differentiation factor 88 display profound defects in host resistance and immune responses to Mycobacterium avium infection not exhibited by Toll-like receptor 2 (TLR2)- and TLR4-deficient animals. J Immunol 2003; 171: 4758-4764.
16. Koh WJ, Lee KS, Kwon OJ, Jeong YJ, Kwak SH, Kim TS. Bilateral bronchiectasis and bronchiolitis at thin-section CT: diagnostic implications in nontuberculous mycobacterial pulmonary infection. Radiology 2005; 235: 282-288.
17. Greinert U, Schlaak M, Rüsch-Gerdes S, Flad HD, Ernst M. Low in vitro production of interferon-γ and tumor necrosis factor-α in HIV-seronegative patients with pulmonary disease caused by nontuberculous mycobacteria. J Clin Immunol 2000; 20: 445-452.
18. Vankayalapati R, Wizel B, Samten B, et al. Cytokine profiles in immunocompetent persons infected with Mycobacterium avium complex. J Infect Dis 2001; 183: 478-484.
19. Underhill DM, Ozinsky A, Smith KD, Aderem A. Toll-like receptor-2 mediates mycobacteria-induced proinflammatory signaling in macrophages. Proc Natl Acad Sci USA 1999; 96: 14459-14463.
20. Heldwein KA, Liang MD, Andresen TK, et al. TLR2 and TLR4 serve distinct roles in the host immune response against Mycobacterium bovis BCG. J Leukoc Biol 2003; 74: 277-286.
21. Sieling PA, Chung W, Duong BT, Godowski PJ, Modlin RL. Toll-like receptor 2 ligands as adjuvants for human Th1 responses. J Immunol 2003; 170: 194-200.
22. Trinchieri G. Interleukin-12 and the regulation of innate resistance and adaptive immunity. Nat Rev Immunol 2003; 3: 133-146.
23. Gomez-Flores R, Tucker SD, Kansal R, Tamez-Guerra R, Mehta RT. Enhancement of antibacterial activity of clofazimine against Mycobacterium avium-Mycobacterium intracellulare complex infection induced by IFN-γ is mediated by TNF-α. J Antimicrob Chemother 1997; 39: 189-197.
24. Kang TJ, Chae GT. Detection of Toll-like receptor 2 (TLR2) mutation in the lepromatous leprosy patients. FEMS Immunol Med Microbiol 2001; 31: 53-58.
25. Ben-Ali M, Barbouche MR, Bousnina S, Chabbou A, Dellagi K. Toll-like receptor 2 Arg677Trp polymorphism is associated with susceptibility to tuberculosis in Tunisian patients. Clin Diagn Lab Immunol 2004; 11: 625-626.
26. Ogus AC, Yoldas B, Ozdemir T, et al. The Arg753Gln polymorphism of the human Toll-like receptor 2 gene in tuberculosis disease. Eur Respir J 2004; 23: 219-223.
27. Yim JJ, Lee HW, Lee HS, et al. The association between microsatellite polymorphisms in intron II of the human Toll-like receptor 2 gene and tuberculosis among Koreans. Genes Immun 2006; 7: 150-155.
28. Ryu YJ, Kim EJ, Koh WJ, Kim H, Kwon OJ, Chang JH. Toll-like receptor 2 polymorphisms and nontuberculous mycobacterial lung diseases. Clin Vaccine Immunol 2006; 13: 818-819.
29. Sable SB, Goyal D, Verma I, Behera D, Khuller GK. Lung and blood mononuclear cell responses of tuberculosis patients to mycobacterial proteins. Eur Respir J 2007; 29: 337-346.
30. Schwander SK, Torres M, Carranza CC, et al. Pulmonary mononuclear cell responses to antigens of Mycobacterium tuberculosis in healthy household contacts of patients with active tuberculosis and healthy controls from the community. J Immunol 2000; 165: 1479-1485.